Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Budesonide 3mg gastro-resistant capsules
0105020A0AAACAC
|
Budesonide (Systemic) | Budesonide | Gastro-Intestinal System | 11,750 |
|
Budesonide 3mg gastro-resistant modified-release capsules
0105020A0AAAAAA
|
Budesonide (Systemic) | Budesonide | Gastro-Intestinal System | 5,458 |
|
Budesonide 2mg/application foam enema
0105020A0AAADAD
|
Budesonide (Systemic) | Budesonide | Gastro-Intestinal System | 2,850 |
|
Budesonide 9mg modified-release tablets
0105020A0AAAFAF
|
Budesonide (Systemic) | Budesonide | Gastro-Intestinal System | 1,866 |
|
Budesonide 1mg orodispersible tablets sugar free
0105020A0AAAGAG
|
Budesonide (Systemic) | Budesonide | Gastro-Intestinal System | 573 |
|
Budesonide 9mg gastro-resistant granules sachets
0105020A0AAAEAE
|
Budesonide (Systemic) | Budesonide | Gastro-Intestinal System | 191 |
|
Budesonide 500microgram orodispersible tablets sugar free
0105020A0AAAHAH
|
Budesonide (Systemic) | Budesonide | Gastro-Intestinal System | 146 |
|
Budesonide 2mg/100ml enema
0105020A0AAABAB
|
Budesonide (Systemic) | Budesonide | Gastro-Intestinal System | 135 |
|
Budesonide 4mg suppositories
0105020A0AAAIAI
|
Budesonide (Systemic) | Budesonide | Gastro-Intestinal System | 28 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.